The fact that the efficacy of the PD/DPH combination was detected only in leukemia cells expressing ABL1 supports the concept that DPH exerted its activity by activating ABL1, but not by displacing HSP90 from BCR::ABL1 [17, 50]. This evidence concerns the gene ABL1 and leukemia.